- CONMED press release ( NYSE: CNMD ): Q4 Non-GAAP EPS of $0.42 misses by $0.48 .
- Revenue of $250.9M (-8.4% Y/Y) misses by $51.58M .
- 2023 Outlook
- The Company expects full-year 2023 reported revenue between $1.170 billion and $1.220 billion vs $1.21B consensus, which includes expected headwind from foreign exchange between 150 and 200 basis points. Adjusted diluted net earnings per share (2) is expected to be in the range of $3.20 to $3.45 vs $3.37 consensus, which includes expected headwind from foreign exchange between $0.20 and $0.25.
For further details see:
CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M